ArticlePharmaceuticals (Basel, Switzerland)2010

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

Paolo Cravedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.